Shilpa Narina

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 12

Top Topics

Disease Activity

Acute Lymphoblastic Leukemia

Protein Protein

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Nature communications

Journal of medicinal chemistry

ACS medicinal chemistry letters

Cell death and differentiation

This page only lists publications with an associated author ORCID identifier.

Publications

Gisele Nishiguchi, Lauren G Mascibroda, Sarah M Young, Elizabeth A Caine, Sherif Abdelhamed, Jeffrey J Kooijman, Darcie J Miller, Sourav Das, Kevin McGowan, Anand Mayasundari, Zhe Shi, Juan M Barajas, Ryan Hiltenbrand, Anup Aggarwal, Yunchao Chang, Vibhor Mishra, Shilpa Narina, Melvin Thomas, Allister J Loughran, Ravi C Kalathur, Kaiwen Yu, Suiping Zhou, Xusheng Wang, Anthony A High, Junmin Peng, Shondra M Pruett-Miller, Danette L Daniels, Marjeta Urh, Anang A Shelat, Charles G Mullighan, Kristin M Riching, Guido J R Zaman, Marcus Fischer, Jeffery M Klco, Zoran Rankovic
Selective CK1α degraders exert antiproliferative activity against a broad range of human cancer cell lines. Nature communications 15 (1) (2024)
Jamie A Jarusiewicz, Satoshi Yoshimura, Marisa Actis, Yong Li, Xiang Fu, Lei Yang, Shilpa Narina, Shondra M Pruett-Miller, Suiping Zhou, Xusheng Wang, Anthony A High, Gisele Nishiguchi, Jun J Yang, Zoran Rankovic
Development of an Orally Bioavailable LCK PROTAC Degrader as a Potential Therapeutic Approach to T-Cell Acute Lymphoblastic Leukemia. Journal of medicinal chemistry (2024)
Jamie A Jarusiewicz, Satoshi Yoshimura, Marisa Actis, Yong Li, Xiang Fu, Lei Yang, Shilpa Narina, Shondra M Pruett-Miller, Suiping Zhou, Xusheng Wang, Anthony A High, Gisele Nishiguchi, Jun J Yang, Zoran Rankovic
Development of an Orally Bioavailable LCK PROTAC Degrader as a Potential Therapeutic Approach to T-Cell Acute Lymphoblastic Leukemia. Journal of medicinal chemistry 67 (14) (2024)
Gisele Nishiguchi, Lauren G Mascibroda, Sarah M Young, Elizabeth A Caine, Sherif Abdelhamed, Jeffrey J Kooijman, Darcie J Miller, Sourav Das, Kevin McGowan, Anand Mayasundari, Zhe Shi, Juan M Barajas, Ryan Hiltenbrand, Anup Aggarwal, Yunchao Chang, Vibhor Mishra, Shilpa Narina, Melvin Thomas, Allister J Loughran, Ravi C Kalathur, Kaiwen Yu, Suiping Zhou, Xusheng Wang, Anthony A High, Junmin Peng, Shondra M Pruett-Miller, Danette L Daniels, Marjeta Urh, Anang A Shelat, Charles G Mullighan, Kristin M Riching, Guido J R Zaman, Marcus Fischer, Jeffery M Klco, Zoran Rankovic
Selective CK1α degraders exert antiproliferative activity against a broad range of human cancer cell lines. Nature communications 15 (1) (2024)
Jamie A Jarusiewicz, Satoshi Yoshimura, Marisa Actis, Yong Li, Xiang Fu, Lei Yang, Shilpa Narina, Shondra M Pruett-Miller, Suiping Zhou, Xusheng Wang, Anthony A High, Gisele Nishiguchi, Jun J Yang, Zoran Rankovic
Development of an Orally Bioavailable LCK PROTAC Degrader as a Potential Therapeutic Approach to T-Cell Acute Lymphoblastic Leukemia. Journal of medicinal chemistry 67 (14) (2024)
Jamie A Jarusiewicz, Satoshi Yoshimura, Marisa Actis, Yong Li, Xiang Fu, Lei Yang, Shilpa Narina, Shondra M Pruett-Miller, Suiping Zhou, Xusheng Wang, Anthony A High, Gisele Nishiguchi, Jun J Yang, Zoran Rankovic
Development of an Orally Bioavailable LCK PROTAC Degrader as a Potential Therapeutic Approach to T-Cell Acute Lymphoblastic Leukemia. Journal of medicinal chemistry 67 (14) (2024)
Gisele Nishiguchi, Lauren G Mascibroda, Sarah M Young, Elizabeth A Caine, Sherif Abdelhamed, Jeffrey J Kooijman, Darcie J Miller, Sourav Das, Kevin McGowan, Anand Mayasundari, Zhe Shi, Juan M Barajas, Ryan Hiltenbrand, Anup Aggarwal, Yunchao Chang, Vibhor Mishra, Shilpa Narina, Melvin Thomas, Allister J Loughran, Ravi C Kalathur, Kaiwen Yu, Suiping Zhou, Xusheng Wang, Anthony A High, Junmin Peng, Shondra M Pruett-Miller, Danette L Daniels, Marjeta Urh, Anang A Shelat, Charles G Mullighan, Kristin M Riching, Guido J R Zaman, Marcus Fischer, Jeffery M Klco, Zoran Rankovic
Selective CK1α degraders exert antiproliferative activity against a broad range of human cancer cell lines. Nature communications 15 (1) (2024)
Gisele Nishiguchi, Lauren G Mascibroda, Sarah M Young, Elizabeth A Caine, Sherif Abdelhamed, Jeffrey J Kooijman, Darcie J Miller, Sourav Das, Kevin McGowan, Anand Mayasundari, Zhe Shi, Juan M Barajas, Ryan Hiltenbrand, Anup Aggarwal, Yunchao Chang, Vibhor Mishra, Shilpa Narina, Melvin Thomas, Allister J Loughran, Ravi C Kalathur, Kaiwen Yu, Suiping Zhou, Xusheng Wang, Anthony A High, Junmin Peng, Shondra M Pruett-Miller, Danette L Daniels, Marjeta Urh, Anang A Shelat, Charles G Mullighan, Kristin M Riching, Guido J R Zaman, Marcus Fischer, Jeffery M Klco, Zoran Rankovic
Selective CK1α degraders exert antiproliferative activity against a broad range of human cancer cell lines. Nature communications 15 (1) (2024)
Gisele Nishiguchi, Lauren G Mascibroda, Sarah M Young, Elizabeth A Caine, Sherif Abdelhamed, Jeffrey J Kooijman, Darcie J Miller, Sourav Das, Kevin McGowan, Anand Mayasundari, Zhe Shi, Juan M Barajas, Ryan Hiltenbrand, Anup Aggarwal, Yunchao Chang, Vibhor Mishra, Shilpa Narina, Melvin Thomas, Allister J Loughran, Ravi C Kalathur, Kaiwen Yu, Suiping Zhou, Xusheng Wang, Anthony A High, Junmin Peng, Shondra M Pruett-Miller, Danette L Daniels, Marjeta Urh, Anang A Shelat, Charles G Mullighan, Kristin M Riching, Guido J R Zaman, Marcus Fischer, Jeffery M Klco, Zoran Rankovic
Selective CK1α degraders exert antiproliferative activity against a broad range of human cancer cell lines. Nature communications 15 (1) (2024)
Jamie A Jarusiewicz, Satoshi Yoshimura, Anand Mayasundari, Marisa Actis, Anup Aggarwal, Kevin McGowan, Lei Yang, Yong Li, Xiang Fu, Vibhor Mishra, Richard Heath, Shilpa Narina, Shondra M Pruett-Miller, Gisele Nishiguchi, Jun J Yang, Zoran Rankovic
Phenyl Dihydrouracil: An Alternative Cereblon Binder for PROTAC Design. ACS medicinal chemistry letters 14 (2) (2023)
Jamie A Jarusiewicz, Satoshi Yoshimura, Anand Mayasundari, Marisa Actis, Anup Aggarwal, Kevin McGowan, Lei Yang, Yong Li, Xiang Fu, Vibhor Mishra, Richard Heath, Shilpa Narina, Shondra M Pruett-Miller, Gisele Nishiguchi, Jun J Yang, Zoran Rankovic
Phenyl Dihydrouracil: An Alternative Cereblon Binder for PROTAC Design. ACS medicinal chemistry letters 14 (2) (2023)
Giovanni Quarato, Fabien Llambi, Cliff S Guy, Jaeki Min, Marisa Actis, Huan Sun, Shilpa Narina, Shondra M Pruett-Miller, Junmin Peng, Zoran Rankovic, Douglas R Green
Ca 2+ -mediated mitochondrial inner membrane permeabilization induces cell death independently of Bax and Bak. Cell death and differentiation 29 (7) (2022)